These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6162063)

  • 1. Interferon treatment of skin cancer in patients with epidermodysplasia verruciformis.
    Blanchet-Bardon C; Puissant A; Lutzner M; Orth G; Nutini MT; Guesry P
    Lancet; 1981 Jan; 1(8214):274. PubMed ID: 6162063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidermodysplasia verruciformis Lewandowsky-Lutz with multiple squamous epithelium and Bowen's carcinomas].
    Haustein UF
    Dermatol Monatsschr; 1982 Dec; 168(12):821-8. PubMed ID: 6301900
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidermodysplasia verruciformis associated with chromosomal abnormality].
    Sawada Y; Ohashi M; Kishi K; Ikeuchi T
    Nihon Hifuka Gakkai Zasshi; 1984 Mar; 94(3):201-5. PubMed ID: 6088856
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis.
    Lutzner MA; Blanchet-Bardon C
    N Engl J Med; 1980 May; 302(19):1091. PubMed ID: 6245361
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
    Baskan EB; Tunali S; Adim SB; Turan A; Toker S
    J Dermatolog Treat; 2006; 17(3):179-83. PubMed ID: 16854762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons in the treatment of skin disease.
    Ringenberg QS; Anderson PC
    Int J Dermatol; 1986 Jun; 25(5):273-9. PubMed ID: 2424849
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon and retinoid treatment of warts.
    Blanchet-Bardon C; Lutzner MA
    Clin Dermatol; 1985; 3(4):195-9. PubMed ID: 2463864
    [No Abstract]   [Full Text] [Related]  

  • 8. Perianal warts and the development of squamous cell carcinoma in epidermodysplasia verruciformis.
    Kivanc-Altunay I; Erdogan HK; Kayaoglu S
    Indian J Dermatol Venereol Leprol; 2011; 77(1):112. PubMed ID: 21220907
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferons: therapeutic potential in cutaneous diseases.
    Vance JC
    Adv Dermatol; 1991; 6():3-33; discussion 34. PubMed ID: 1701320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lewandowsky-Lutz epidermodysplasia verruciformis as a precancerous state].
    Jablońska S; Jakubowicz K; Langner A; Biczysko W; Dabrowski J
    Przegl Dermatol; 1969; 56(6):715-9. PubMed ID: 5368724
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin cancer in epidermodysplasia verruciformis patients from Brazil.
    Oliveira WR; Rady PL; Festa C; Rivitti EA; Tyring SK
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1154-6. PubMed ID: 16987289
    [No Abstract]   [Full Text] [Related]  

  • 12. Squamous cell carcinoma arising in hidradenitis suppurativum.
    Humphrey LJ; Playforth H; Leavell UW
    Arch Dermatol; 1969 Jul; 100(1):59-62. PubMed ID: 5394363
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon.
    Greenway HT
    West J Med; 1994 Apr; 160(4):363. PubMed ID: 7517599
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous squamous cell carcinoma with epidermodysplasia verruciformis-like features in a patient with Schimke immune-osseous dysplasia.
    Collins MK; Peters K; English JC; Rady P; Tyring S; Jedrych J
    J Cutan Pathol; 2018 Jun; 45(6):465-467. PubMed ID: 29498428
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
    Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
    J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interferon in therapy of skin and head and neck tumors.
    Padovan I; Brodarec I; Ikić D; Knezević M; Soos E
    J Cancer Res Clin Oncol; 1981; 100(3):295-310. PubMed ID: 6168641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus infection and its relationship to skin cancer in a group of renal allograft recipients.
    Benton EC; McLaren K; Barr BB; Blessing K; Bunney MH; Rüdlinger R; Smith IW; Hunter JA
    Curr Probl Dermatol; 1989; 18():168-77. PubMed ID: 2545416
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon: status in treatment of skin disease.
    Yancey KB; Smith JG
    J Am Acad Dermatol; 1980 Dec; 3(6):585-95. PubMed ID: 6162867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon. Promises, disappointments, and tempered optimism.
    Edwards L
    Arch Dermatol; 1987 Jun; 123(6):743-4. PubMed ID: 2437865
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis.
    Orth G; Jablonska S; Jarzabek-Chorzelska M; Obalek S; Rzesa G; Favre M; Croissant O
    Cancer Res; 1979 Mar; 39(3):1074-82. PubMed ID: 218721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.